011 World Cancer Day 2016 news -...

1
4 th February 2016 Raising awareness of cancer and cancer research – World Cancer Day World Cancer Day is held annually on 4 th February to raise global awareness of the disease, research into curative and preventative therapies, and to highlight the services and activities of organisations and charities specifically established to support patients and families effected by cancer. WCD was established by the Paris Chapter adopted at the World Summit Against Cancer for the New Millenium, in Paris, on 4 th February 2000 (Union for International Cancer Control (UICC) http://www.worldcancerday.org). To mark this day, in collaboration with Cancer Research UK | Oxford Centre, students Simon Werrel and Christian Kuper, welcomed members of the public to the Chemistry Research Laboratory, University of Oxford to showcase the facilities, and the work led by the OxIOSCR researchers. Christian began the session with a brief overview of the project and an explanation of how the students are working towards the development of natural-product like compounds with anti-cancer properties. The interactive session enabled visitors to ask questions and get a feel for how the researchers work towards the project objectives. The students led the audience on a tour of the facilities with a visit to a lab where separation techniques (chromatography and distillation) were demonstrated, finishing with an introduction to the mass spectrometry facilities by James Wickens. This was a busy hour with an exclusive look behind the scenes in Chemistry and Cancer Research; as part of the day’s activities further behind the scenes tours were organised at the Department of Physiology, Anatomy and Genetics (DPAG) and the William Dunn School of Pathology. _______________________________________________________________________________________________________________ This project has received support from Cancer Research UK (CR-UK) grant number C38302/A13012 through the CRUK Oxford Centre. This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement number: 316955.

Transcript of 011 World Cancer Day 2016 news -...

Page 1: 011 World Cancer Day 2016 news - oxioscr.chem.ox.ac.ukoxioscr.chem.ox.ac.uk/resources/...Day_2016__news.pdf · WCD was established by the Paris Chapter adopted at the World Summit

4thFebruary2016Raisingawarenessofcancerandcancerresearch–WorldCancerDayWorldCancerDayisheldannuallyon4thFebruarytoraiseglobal awareness of the disease, research into curativeandpreventative therapies, and tohighlight the servicesand activities of organisations and charities specificallyestablished to support patients and families effected bycancer. WCD was established by the Paris Chapteradoptedat theWorld SummitAgainst Cancer for theNewMillenium, in Paris, on 4th February 2000 (Union for International Cancer Control (UICC)http://www.worldcancerday.org).Tomark this day, in collaboration with Cancer Research UK | Oxford Centre, students SimonWerrel and Christian Kuper, welcomed members of the public to the Chemistry ResearchLaboratory, University of Oxford to showcase the facilities, and the work led by the OxIOSCRresearchers.Christianbeganthesessionwithabriefoverviewoftheprojectandanexplanationofhow the students areworking towards thedevelopmentofnatural-product like compoundswithanti-cancerproperties. Theinteractivesessionenabledvisitorstoaskquestionsandgeta

feel for how the researchers work towards the projectobjectives. The students led the audience on a tour of thefacilities with a visit to a lab where separation techniques(chromatography and distillation) were demonstrated,finishing with an introduction to the mass spectrometryfacilities by JamesWickens. Thiswas a busy hourwith anexclusive look behind the scenes in Chemistry and CancerResearch; as part of the day’s activities further behind the

scenestourswereorganisedattheDepartmentofPhysiology,AnatomyandGenetics(DPAG)andtheWilliamDunnSchoolofPathology._______________________________________________________________________________________________________________

This project has received support from Cancer Research UK (CR-UK) grant number C38302/A13012 through the CRUK Oxford Centre.

This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement number: 316955.